SwissMedic-2021-0049-V249
Type II variation for application SwissMedic-2021-0049. Type II variation: Formulation Change for Raredimab — routine update
Variation Number
SwissMedic-2021-0049-V249
Type
Type II
Application
Change
Status
Active
Fee
€62,826
Submitted
—
Approved
—
Description
Type II variation: Formulation Change for Raredimab — routine update